Notch1
Notch1 (notch receptor 1, also known as TAN1) is a type I transmembrane receptor of the NOTCH family. It binds membrane-bound ligands on neighbouring cells and regulates cell-fate determination, differentiation, proliferation and apoptosis. Browse Assay Genie's current range of Notch1 research reagents below, or read on for the biology behind the target.
Notch1 functions as a receptor for the membrane-bound ligands Jagged-1 (JAG1), Jagged-2 (JAG2) and Delta-1 (DLL1). Following ligand activation, the released Notch intracellular domain (NICD) forms a transcriptional activator complex with RBPJ/RBPSUH and switches on genes of the enhancer of split locus. In this way Notch signalling, an evolutionarily conserved intercellular pathway, regulates interactions between physically adjacent cells and shapes differentiation, proliferation and apoptotic programmes.
The Notch1 gene encodes a preproprotein that is proteolytically processed in the trans-Golgi network into two polypeptide chains. These heterodimerise to form the mature cell-surface receptor. The extracellular region contains multiple epidermal growth factor-like (EGF) repeats, while the intracellular region is made up of several different domain types. UniProt lists localisation to the cell membrane, late endosome membrane and nucleus.
Reported roles are broad. Notch1 is involved in angiogenesis, where it negatively regulates endothelial cell proliferation, migration and angiogenic sprouting. It contributes to the maturation of CD4(+) and CD8(+) cells in the thymus, to follicular differentiation, and to Bergmann glia differentiation in the developing cerebellum, where neuronal DNER acts as a ligand. It represses neuronal and myogenic differentiation, helps determine left/right symmetry by balancing motile and immotile cilia at the left-right organiser, and may enhance HIF1A function by sequestering HIF1AN. Mutations in the gene are associated with aortic valve disease, Adams-Oliver syndrome, T-cell acute lymphoblastic leukaemia, chronic lymphocytic leukaemia and head and neck squamous cell carcinoma. Mouse and rat orthologs are both named Notch1.
Notch1 regulates cell-fate determination and may contribute to mesoderm development, somite formation and neurogenesis.
Mutations in Notch1 are associated with T-cell acute lymphoblastic leukaemia, chronic lymphocytic leukaemia and head and neck squamous cell carcinoma.
Notch1 negatively regulates endothelial cell proliferation, migration and angiogenic sprouting, and mutations are linked to aortic valve disease.
Notch1 is involved in the maturation of both CD4(+) and CD8(+) cells in the thymus.
Notch1 is a cell-surface receptor for JAG1, JAG2 and DLL1. Ligand binding releases the Notch intracellular domain, which partners with RBPJ to activate enhancer of split genes. This pathway influences differentiation, proliferation and apoptosis in many cell and tissue types.
The HGNC symbol is NOTCH1 and the alias is TAN1, from earlier names such as Notch homolog 1, translocation-associated (Drosophila). UniProt calls the protein neurogenic locus notch homolog protein 1. The precursor is cleaved into two chains that heterodimerise at the cell surface.
Mutations in the Notch1 gene are associated with aortic valve disease, Adams-Oliver syndrome, T-cell acute lymphoblastic leukaemia, chronic lymphocytic leukaemia and head and neck squamous cell carcinoma. Mouse and rat both have a Notch1 ortholog; check the datasheet of any product for its validated reactivity.
Other Notch receptor family members and related Notch-pathway targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P46531; product specifications from Assay Genie datasheets.